Source - LSE Regulatory
RNS Number : 9319V
JPMorgan Claverhouse IT PLC
19 April 2021
| JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC (the 'Company') | |
| Legal Entity Identifier: 549300NFZYYFSCD52W53 | |
| THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 31 March 2021 | |
| Royal Dutch Shell | 5.4% |
| JPMorgan Smaller Companies Inv Trust | 4.9% |
| AstraZeneca | 4.2% |
| Rio Tinto | 3.8% |
| British American Tobacco | 3.2% |
| BP | 3.1% |
| BHP | 2.9% |
| Prudential | 2.8% |
| Barclays | 2.7% |
| GlaxoSmithKline | 2.7% |
| Total | 35.7% |
| Excludes Investments in Liquidity stocks | |
| Name of contact and telephone number for queries: | |
| Paul Ainger 0044 207 742 6524 | |
| Name of authorised company official responsible for making this notification: | |
| Paul Winship 0044 207 742 9815 - Company Secretary | |
| Date: 19 April 2021 | |
| | |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
